Cargando…

Expression of secretory leukocyte protease inhibitor detected by immunohistochemistry correlating with prognosis and metastasis in colorectal cancer

BACKGROUND: The potential of secretory leukocyte protease inhibitor (SLPI) as a biomarker for colorectal cancer was studied. A prospective, randomized, controlled, clinical trial was conducted in 2013 and 2014 to confirm whether the expression of SLPI correlates with prognosis and metastasis in colo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Guiying, Yang, Jingyan, Zhao, Yulei, Wang, Zhijing, Xing, Baoheng, Wang, Liang, Shi, Dongliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265488/ https://www.ncbi.nlm.nih.gov/pubmed/25441765 http://dx.doi.org/10.1186/1477-7819-12-369

Ejemplares similares

Inhibition of secretory leukocyte protease inhibitor (SLPI) promotes the PUMA-mediated apoptosis and chemosensitivity to cisplatin in colorectal cancer cells
por: Wei, Zhijiang, et al.
Publicado: (2023)

Targeting secretory leukocyte protease inhibitor (SLPI) inhibits colorectal cancer cell growth, migration and invasion via downregulation of AKT
por: Wei, Zhijiang, et al.
Publicado: (2020)

Immunoregulatory role of secretory leukocyte protease inhibitor in allergic asthma
por: Marino, Rafael, et al.
Publicado: (2010)

Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers
por: Kozin, Sergey V., et al.
Publicado: (2017)

Effect of Semen on Vaginal Fluid Cytokines and Secretory Leukocyte Protease Inhibitor
por: Agnew, Kathy J., et al.
Publicado: (2008)

Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis
por: Nugteren, Sandrine, et al.
Publicado: (2020)

Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa.
por: Nyström, M, et al.
Publicado: (2001)

Endogenous secretory leukocyte protease inhibitor inhibits microbial‐induced monocyte activation
por: Nugteren, Sandrine, et al.
Publicado: (2022)

Secretory Leukocyte Protease Inhibitor Is an Inducible Antimicrobial Peptide Expressed in Staphylococcus aureus Endophthalmitis
por: Reviglio, Victor E., et al.
Publicado: (2007)

Human papillomavirus infection in head and neck cancer: The role of the secretory leukocyte protease inhibitor
por: HOFFMANN, MARKUS, et al.
Publicado: (2013)

The cardioprotective effects of secretory leukocyte protease inhibitor against myocardial ischemia/reperfusion injury
por: Prompunt, Eakkapote, et al.
Publicado: (2018)

Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome
por: Dickey, Brittney L., et al.
Publicado: (2021)

Secretory leukocyte protease inhibitor and risk of heart failure in the Multi-Ethnic Study of Atherosclerosis
por: Sawicki, Konrad Teodor, et al.
Publicado: (2023)

Secretory Leukocyte Protease Inhibitor Protects Against Severe Urinary Tract Infection in Mice
por: Rosen, Anne L., et al.
Publicado: (2023)

The Ability of Secretory Leukocyte Protease Inhibitor to Inhibit Apoptosis in Monocytes Is Independent of Its Antiprotease Activity
por: McGarry, Niamh, et al.
Publicado: (2015)

Upregulated Expression of Secretory Leukocyte Protease Inhibitor in Lung by Inhalation of High Concentration of Sulfur Dioxide
por: Liu, Lei, et al.
Publicado: (2018)

Secretory leukocyte protease inhibitor regulates nerve reflex‐mediated skin barrier function in psoriasis
por: Kwiecinska, P., et al.
Publicado: (2022)

Elevated Concentrations of SERPINE2/Protease Nexin-1 and Secretory Leukocyte Protease Inhibitor in the Serum of Patients with Papillary Thyroid Cancer
por: Stępień, Tomasz, et al.
Publicado: (2017)

Anti-Protease Activity Deficient Secretory Leukocyte Protease Inhibitor (SLPI) Exerts Cardioprotective Effect against Myocardial Ischaemia/Reperfusion
por: Mongkolpathumrat, Podsawee, et al.
Publicado: (2022)

Secretory Leukocyte Protease Inhibitor Suppresses the Inflammation and Joint Damage of Bacterial Cell Wall–Induced Arthritis
por: Song, Xiao-yu, et al.
Publicado: (1999)

Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection
por: Ma, Ge, et al.
Publicado: (2004)

Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression
por: Wex, Thomas, et al.
Publicado: (2011)

Effects of Pregnancy and Bacterial Vaginosis on Proinflammatory Cytokine and Secretory Leukocyte Protease Inhibitor Concentrations in Vaginal Secretions
por: Balkus, Jennifer, et al.
Publicado: (2010)

Increased Secretory Leukocyte Protease Inhibitor (SLPI) Production by Highly Metastatic Mouse Breast Cancer Cells
por: Sayers, Kevin T., et al.
Publicado: (2014)

Estimation and Comparison of Salivary Secretory Leukocyte Protease Inhibitor in Human Immunodeficiency Virus Patients and Healthy Individuals
por: Pushpanshu, Kumar, et al.
Publicado: (2014)

Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines
por: Svensson, Daniel, et al.
Publicado: (2017)

Secretory Leukocyte Protease Inhibitor Is Present in Circulating and Tissue-Recruited Human Eosinophils and Regulates Their Migratory Function
por: Osiecka, Oktawia, et al.
Publicado: (2022)

Spatiotemporal expression and regulation of peptidase inhibitor 3 and secretory leukocyte protease inhibitor at the maternal–fetal interface in pigs
por: Lee, Soohyung, et al.
Publicado: (2023)

High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence
por: Nugteren, Sandrine, et al.
Publicado: (2022)

An in vitro endothelial cell protective effect of secretory leukocyte protease inhibitor against simulated ischaemia/reperfusion injury
por: Nernpermpisooth, Nitirut, et al.
Publicado: (2017)

Secretory leukocyte protease inhibitor gene deletion alters bleomycin-induced lung injury, but not development of pulmonary fibrosis
por: Habgood, Anthony N, et al.
Publicado: (2016)

Airway Microbiota-Host Interactions Regulate Secretory Leukocyte Protease Inhibitor Levels and Influence Allergic Airway Inflammation
por: Jaeger, Natalia, et al.
Publicado: (2020)

Airway Microbiota-Host Interactions Regulate Secretory Leukocyte Protease Inhibitor Levels and Influence Allergic Airway Inflammation
por: Jaeger, Natalia, et al.
Publicado: (2022)

Secretory Leukocyte Protease Inhibitor (SLPI) Is, like Its Homologue Trappin-2 (Pre-Elafin), a Transglutaminase Substrate
por: Baranger, Kévin, et al.
Publicado: (2011)

The Phospholipid Scramblases 1 and 4 Are Cellular Receptors for the Secretory Leukocyte Protease Inhibitor and Interact with CD4 at the Plasma Membrane
por: Py, Bénédicte, et al.
Publicado: (2009)

Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1
por: Påhlman, Lisa I, et al.
Publicado: (2015)

Plasma concentrations of secretory leukocyte protease inhibitor (SLPI) differ depending on etiology and severity in community-onset bloodstream infection
por: Lange, Anna, et al.
Publicado: (2019)

Endothelial-Cell-Derived Human Secretory Leukocyte Protease Inhibitor (SLPI) Protects Cardiomyocytes against Ischemia/Reperfusion Injury
por: Kongpol, Kantapich, et al.
Publicado: (2019)

Secretory leukocyte protease inhibitor suppresses HPV E6-expressing HNSCC progression by mediating NF-κB and Akt pathways
por: Jin, Yu, et al.
Publicado: (2019)

Correction: The Phospholipid Scramblases 1 and 4 Are Cellular Receptors for the Secretory Leukocyte Protease Inhibitor and Interact with CD4 at the Plasma Membrane
por: Py, Bénédicte, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_mdv9a5l26eoa6kl8km9fa3tjdl